Answers are grounded in this paper and cite their sources.
Background/Objectives: To determine whether prior cardiovascular disease (CVD) independently predicts diabetic retinopathy (DR) in adults with newly diagnosed type 2 diabetes mellitus (T2DM). Methods: A retrospective nationwide population-based cohort study was conducted using the Korean National Health Insurance Service database. Adults aged ≥40 years with newly diagnosed T2DM were identified after a 7-year washout period. After 1:1 propensity score matching on age and sex, the analytical cohort comprised 38,812 patients per group. Results: After full covariate adjustment, prior CVD was not independently associated with any DR (HR, 1.01; 95% confidence interval [CI], 0.99–1.04; p = 0.262), NPDR (HR, 1.01; 95% CI, 0.98–1.03; p = 0.605), PDR (HR, 1.01; 95% CI, 0.95–1.06; p = 0.835), or VTDR (HR, 1.00; 95% CI, 0.95–1.06; p = 0.893). Fine–Gray models, accounting for higher all-cause mortality in the prior CVD group after matching (25.2% vs. 22.1%), revealed slightly lower sHR for any DR (sHR, 0.97; 95% CI, 0.95–0.99; p = 0.014) and NPDR (sHR, 0.97; 95% CI, 0.94–0.99; p = 0.005). Conclusions: Prior CVD was not independently associated with incident DR. The lower sHRs may partly reflect competing mortality and should not be interpreted as DR protection. Overall, CVD history was not a criterion for intensified DR screening.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: